Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean Population.

Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation

NCT01795378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma

NCT06749925 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer

NCT01897207 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Dendritic Cell Based Therapy of Malignant Melanoma

NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

NCT03395587 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients

NCT07317154 ·Status: RECRUITING ·Phase: PHASE1

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

NCT00327496 ·Status: UNKNOWN ·Phase: NA

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study

NCT01973322 ·Status: COMPLETED ·Phase: PHASE2

Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients

NCT01690377 ·Status: COMPLETED ·Phase: PHASE1

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

NCT01171469 ·Status: COMPLETED ·Phase: PHASE1

Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme

NCT00323115 ·Status: COMPLETED ·Phase: PHASE2

Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

NCT02248402 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Infections Associated With the Use of Alemtuzumab

NCT01315457 ·Status: COMPLETED

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

NCT01671592 ·Status: COMPLETED ·Phase: PHASE1

T Cell Response in Hypersensitivity Syndrome

NCT00213447 ·Status: COMPLETED

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

NCT01235845 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor

NCT04214717 ·Status: UNKNOWN ·Phase: NA

Lymphocytes Subpopulation in Cancer Patients

NCT02516371 ·Status: UNKNOWN ·Phase: NA

Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer

NCT04789252 ·Status: RECRUITING

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

NCT00846456 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

NCT02049489 ·Status: COMPLETED ·Phase: PHASE1

Personalized DC Vaccine for Lung Cancer

NCT02956551 ·Status: UNKNOWN ·Phase: PHASE1

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

NCT05809752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

NCT00576537 ·Status: COMPLETED ·Phase: PHASE2

Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer

NCT00795977 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2